Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 10323820.
- Also identified by PMC identifier 27873.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine the extent to which implementation of an evidence based treatment, antithrombotic treatment in atrial fibrillation, is possible in general practice. Audit and qualitative study of patients with atrial fibrillation and an educational intervention for patients judged eligible for antithrombotic treatment. South east England. 56 patients with a history of atrial fibrillation. Assessment and interview to ascertain patients' views on antithrombotic treatment. Number of patients receiving antithrombotic treatment. Out of 13 239 patients, 132 had a history of atrial fibrillation of which 100 were at risk of thromboembolism. After the study, 52 patients were taking warfarin. Of the remaining 48 patients (of whom 41 were taking aspirin), eight were too ill to participate, 16 were unable to consent, four refused the interview, and 20 declined warfarin. Patients declining warfarin were inclined to seek a higher level of benefit than those taking it, as measured by the minimal clinically important difference. Qualitative data obtained during the interviews suggested that patients' health beliefs were important factors in determining their choice of treatment. Patients' unwillingness to take warfarin seemed to be a major factor in limiting the number who would eventually take it.
Medical subject headings
- Atrial Fibrillation
- Fibrinolytic Agents